BMRA

Biomerica Inc

Apr 08 • 04:00PM ET

2.15

-0.01 -0.46 %

Healthcare • Medical Devices • USA • NASD

Peers: ABT BDX BAX HOLX DXCM QDEL TMO IDXX ILMN PODD

Index	-	P/E	-	EPS (ttm)	-1.54	Insider Own	15.02%	Shs Outstand	2.95M	Perf Week	1.42%
Market Cap	6.49M	Forward P/E	-	EPS next Y	-	Insider Trans	0.00%	Shs Float	2.57M	Perf Month	-1.83%
Enterprise Value	4.23M	PEG	-	EPS next Q	-	Inst Own	2.96%	Short Float	1.76%	Perf Quarter	-19.48%
Income	-4.03M	P/S	1.46	EPS this Y	-	Inst Trans	-2.99%	Short Ratio	2.15	Perf Half Y	-26.62%
Sales	4.46M	P/B	1.43	EPS next Y	-	ROA	-60.49%	Short Interest	0.05M	Perf YTD	-14.68%
Book/sh	1.50	P/C	2.56	EPS next 5Y	-	ROE	-84.30%	52W High	4.88 -55.94%	Perf Year	-44.52%
Cash/sh	0.84	P/FCF	-	EPS past 3/5Y	8.87% -3.30%	ROIC	-90.76%	52W Low	1.87 15.20%	Perf 3Y	-84.55%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	-34.47% -4.52%	Gross Margin	5.61%	Volatility	4.30% 5.42%	Perf 5Y	-94.95%
Dividend TTM	-	EV/Sales	0.95	EPS Y/Y TTM	41.89%	Oper. Margin	-118.10%	ATR (14)	0.12	Perf 10Y	-81.21%
Dividend Ex-Date	-	Quick Ratio	2.29	Sales Y/Y TTM	-20.05%	Profit Margin	-90.29%	RSI (14)	51.19	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	3.25	EPS Q/Q	-2.25%	SMA20	2.31%	Beta	0.25	Target Price	6.25
Payout	-	Debt/Eq	0.06	Sales Q/Q	-26.04%	SMA50	-0.63%	Rel Volume	0.38	Prev Close	2.16
Employees	54	LT Debt/Eq	0.00	Earnings	-	SMA200	-20.10%	Avg Volume	21.00K	Price	2.15
IPO	Mar 17, 1980	Option/Short	No / Yes	EPS/Sales Surpr.	- -	Trades		Volume	7,884	Change	-0.46%

Date	Action	Analyst	Rating Change	Price Target Change
Nov-10-20	Initiated	Colliers Securities	Buy	$13
Jan-04-18	Initiated	B. Riley FBR, Inc.	Buy	$7.50

Mar-18-26 08:19AM	Biomerica Receives First Commercial Order for its H. pylori test (Hp Detect) from One of the Largest Clinical Laboratory Chains in Europe (GlobeNewswire)
Mar-05-26 08:19AM	Biomerica Receives MHRA Registration for hp+detect, Allowing Commercial Sales in Great Britain (GlobeNewswire)
Feb-26-26 08:19AM	Biomerica Reports Real-World Data: Nearly 60% of IBS Patients Achieved Clinically Meaningful Pain Reduction and 68% Achieved Bloating Reduction with the inFoods IBS Therapy (GlobeNewswire) -5.09%
Feb-18-26 08:19AM	Vietnam Approves Biomerica's EZ Detect for Nationwide Distribution (GlobeNewswire)
Jan-14-26 05:17PM	Biomerica Reports Second Quarter Fiscal 2026 Financial Results (GlobeNewswire)
08:19AM	Loading…
Dec-23-25 08:19AM	Biomerica Announces CMS Medicare Payment Rate of $300 for Revolutionary inFoods IBS Test (GlobeNewswire) +10.55%
Dec-11-25 08:08AM	Egyptian Drug Authority Authorizes Biomerica's Complete Screening Test Portfolio (GlobeNewswire)
Nov-25-25 08:19AM	Biomerica's inFoods IBS Product Featured in Biotherapeutics Quarterly, a Henry Schein Publication, Highlighting a New Precision Approach for Treating IBS (GlobeNewswire)
Nov-06-25 08:19AM	Biomerica Expands Contract Development and Manufacturing Services to Meet Growing Market Demand (GlobeNewswire)
Oct-16-25 08:19AM	Henry Schein and Biomerica Enter into Marketing Services Agreement for Biomerica's inFoods IBS Test in the U.S. (GlobeNewswire) +5.24%
Oct-15-25 09:27AM	Biomerica Reports First Quarter Fiscal 2026 Financial Results (GlobeNewswire)
Oct-08-25 08:19AM	Gary Huff, Former CEO of LabCorp Diagnostics, Appointed to Biomerica Board of Directors (GlobeNewswire)
Sep-09-25 08:08AM	Biomerica Launches AI-Backed inFoods IBS Trigger Food Navigator to Support Personalized IBS Therapy and Improve Patient Outcomes (GlobeNewswire)
Sep-03-25 08:19AM	United Arab Emirates Ministry of Health and Prevention Approves Biomerica's Fortel Kidney Test for Home Use (GlobeNewswire) -5.00%
Aug-29-25 05:12PM	Biomerica Reports Fiscal 2025 Year End Results (GlobeNewswire)
05:07AM	Loading…
Aug-18-25 05:07AM	Biomerica receives approval in UAE for at-home ulcer test (Medical Device Network)
Aug-14-25 10:30AM	BC-Most Active Stocks (Associated Press Finance) +15.84%
08:19AM	United Arab Emirates Ministry of Health and Prevention Approves Biomerica's Fortel Ulcer Test for Home Use (GlobeNewswire)
Jul-02-25 08:08AM	InFoods IBS receives CPT Proprietary Laboratory Analysis (PLA) Code (GlobeNewswire)
Jun-26-25 08:19AM	Clinical Diagnostics Industry Leader Scott Madel Joins Biomerica's Team as Chief Commercial Officer (GlobeNewswire)
Jun-06-25 09:30AM	Biomerica Appoints Eric B. Chin to Board of Directors and Audit Committee Chair (GlobeNewswire)
Jun-05-25 08:19AM	Biomerica's inFoods IBS Clinical Study Results Published in June Issue of Gastroenterology (GlobeNewswire)
May-22-25 08:19AM	Biomerica Reports Real-World Data Showing 49% Reduction in IBS Symptoms with inFoods IBS using a First of Its Kind Real-Time IBS Patient Feedback System (GlobeNewswire)
May-07-25 08:19AM	PLA Code Application Filed for inFoods IBS Test - A Key Step Toward Reimbursement (GlobeNewswire) +5.26%
Apr-23-25 08:19AM	United Arab Emirates Ministry of Health and Prevention Approves Biomerica's Fortel Ulcer Test for Detection of H. pylori Infection (GlobeNewswire) +9.25%
Apr-21-25 09:02AM	Biomericas kidney disease test gains approval for sale in UAE (Medical Device Network)
Apr-17-25 08:19AM	United Arab Emirates Ministry of Health and Prevention Approves Biomerica's Fortel Kidney Disease Test for Early Detection of Kidney Damage (GlobeNewswire) +14.28%
Apr-16-25 09:00AM	Biomerica Announces Reverse Stock Split (GlobeNewswire) -26.29%
Apr-15-25 08:19AM	Biomerica Reports Third Quarter Fiscal 2025 Financial Results (GlobeNewswire)
Feb-27-25 05:18AM	Biomericas tests for IBD conditions gain CE-marking under EUs IVDR (Medical Device Network)
08:19AM	Loading…
Feb-26-25 08:19AM	Biomerica Achieves IVDR Certification in the European Union for Food Intolerance Tests Targeting Crohn's Disease and Ulcerative Colitis (GlobeNewswire) +9.39%
Feb-19-25 08:19AM	Biomerica's inFoods IBS Clinical Trial Results Published and Featured in Gastroenterology, the Leading GI Medical Journal (GlobeNewswire) -8.46%
Jan-17-25 10:48AM	Biomericas prostate cancer detection test gains approval from MOHAP (Medical Device Network) -9.35%
Jan-16-25 08:19AM	United Arab Emirates Ministry of Health and Prevention Approves Biomerica's Fortel PSA Screening Test to Detect an Early Sign of Prostate Cancer (GlobeNewswire) +101.71%
Jan-15-25 08:19AM	Biomerica Reports Second Quarter Fiscal 2025 Financial Results (GlobeNewswire) +6.84%
Nov-21-24 08:19AM	Biomerica Secures Three Key International Patents for inFoods Technology to Address GERD, Crohn's Disease, and Ulcerative Colitis (GlobeNewswire)
Nov-07-24 09:09AM	Nasdaq grants Biomerica an additional 180 days to meet listing compliance requirements (GlobeNewswire) +6.11%
Oct-30-24 08:19AM	Biomerica Announces Direct-to-Consumer Availability of inFoods IBS Test, Targeting Relief for Bloating and Gastrointestinal Pain (GlobeNewswire) +18.75%
Oct-16-24 09:00AM	Biomerica Reports First Quarter Fiscal 2025 Financial Results (GlobeNewswire) +9.00%
Sep-04-24 08:19AM	The Saudi Food and Drug Authority (SFDA) Approves Biomerica's At Home PSA Screening Test to Detect Early Signs of Prostate Cancer (GlobeNewswire) -11.67%
Aug-29-24 09:00AM	Biomerica Reports Fiscal 2024 Year End Results (GlobeNewswire)
Jul-16-24 07:43AM	Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday (InvestorPlace)
Jul-01-24 07:47AM	Biomerica Launches At-Home Sample Collection for inFoods IBS, Significantly Expanding Access for Millions of IBS Sufferers (GlobeNewswire)
May-13-24 08:19AM	Biomerica Announces inFoods IBS Pilot Launch with Prominent 1,100 Member Physician Group Commencing June 2024 (GlobeNewswire)
Apr-29-24 11:33AM	Biomerica Enters Distribution Deal to Provide Home Screening Tests in UAE (MT Newswires) -19.95%
08:19AM	Biomerica and Leading UAE Healthcare Company Forge a Path to Enhanced Colorectal and Breast Screening with Exclusive Multi-Year Distribution Agreement (GlobeNewswire)
Apr-15-24 07:47AM	Biomerica provides update on inFoods IBS expansion (GlobeNewswire) -7.00%
Apr-12-24 10:52PM	BMRA Stock Earnings: Biomerica Reported Results for Q3 2024 (InvestorPlace)
07:23PM	Biomerica Reports Third Quarter 2024 Financial Results (GlobeNewswire)
Mar-28-24 08:19AM	Biomerica InFoods IBS Data to be Presented at the Upcoming Digestive Disease Week (DDW) 2024 Conference (GlobeNewswire) -6.52%
Feb-21-24 08:19AM	Diagnostics Industry Leader Gary Huff Appointed to Biomerica Strategic Advisory Board (GlobeNewswire) +5.37%
Jan-23-24 08:19AM	Diagnostics Industry Leader Jack Kenny Appointed as Chairman of the Board at Biomerica (GlobeNewswire) +6.59%
Jan-16-24 02:51PM	BMRA Stock Earnings: Biomerica Reported Results for Q2 2024 (InvestorPlace)
08:19AM	Biomerica Reports Second Quarter 2024 Financial Results (GlobeNewswire)
Dec-20-23 08:30AM	Joshua S. Horowitz Elected Chairman of the Board of Directors of BK Technologies (ACCESSWIRE)
Dec-18-23 07:47AM	Biomerica Received US FDA 510(k) Clearance for Their Hp Detect ELISA Test Product Designed to Detect the Presence of the H. pylori Bacteria That infects Approximately 35% of the U.S. Population (GlobeNewswire) +66.67%
Nov-10-23 08:19AM	Biomerica to Participate in 14th Annual Craig-Hallum Alpha Select Conference on November 16 (GlobeNewswire)
Nov-08-23 08:19AM	Biomerica Expands inFoods IBS Reach with Addition of Several New GI Groups (GlobeNewswire) +11.11%
Oct-13-23 01:10PM	REPEAT - Biomerica Reports First Quarter 2024 Financial Results (GlobeNewswire)
06:39AM	Biomerica Reports First Quarter 2024 Financial Results (GlobeNewswire)
Sep-26-23 08:19AM	Dubai Government Grants Insurance Reimbursement for Biomericas EZ Detect Colorectal Disease Screening Test (GlobeNewswire) -10.66%
Sep-22-23 03:05PM	Maxim Group LLC to Host the Virtual Tech Conference Series: Emerging Growth in A.I., on Tuesday, September 26th & Wednesday, September 27th at 8:00 A.M. ET. (GlobeNewswire)
Aug-28-23 08:19AM	Diagnostics Industry Leader Jack Kenny Joins Biomericas Board of Directors (GlobeNewswire)
Aug-25-23 05:00PM	Biomerica Reports Fiscal 2023 Year End Results (GlobeNewswire)
Aug-03-23 08:19AM	CVS Health to Begin Nationwide In-Store Sales of Biomericas EZ Detect Colorectal Disease Screening Test (GlobeNewswire) +13.01%
Jun-21-23 08:19AM	Biomerica Receives Notice of Patent Allowance in China for a Potential Innovative Technology That Includes an Artificial Intelligence (AI) Claim for Predicting Foods That Contain Ingredients That Cause Adverse Reactions in Patients (GlobeNewswire)
May-18-23 08:19AM	inFoods® IBS Test Now Validated for Use with Simple Finger Stick Whole Blood Collection Technology (GlobeNewswire) +15.00%
Apr-17-23 07:47AM	Biomericas inFoods® IBS test is now available at Gastro Health, providing a revolutionary new treatment for patients suffering from Irritable Bowel Syndrome (IBS). (GlobeNewswire)
Apr-14-23 04:48PM	Biomerica Reports Q3 Fiscal 2023 Results (GlobeNewswire)
Mar-08-23 08:19AM	Biomerica announces the Launch of InFoods IBS as a Laboratory Developed Test (LDT); First patient samples have been processed (GlobeNewswire)
Mar-07-23 04:39PM	Biomerica Announces Closing of $8 Million Underwritten Public Offering of Common Stock (GlobeNewswire)
Mar-03-23 07:30AM	Biomerica Announces Pricing of $8 Million Underwritten Public Offering of Common Stock (GlobeNewswire) -19.06%
Mar-02-23 05:15PM	Biomerica Announces Proposed Underwritten Public Offering of Common Stock (GlobeNewswire)
Feb-20-23 05:57AM	We're Keeping An Eye On Biomerica's (NASDAQ:BMRA) Cash Burn Rate (Simply Wall St.)
Jan-23-23 06:00AM	Barnwell Industries, Inc. Reaches Cooperation and Support Agreement With its Largest Stockholders (GlobeNewswire)
Jan-13-23 06:39PM	Biomerica Reports Financial Results for Fiscal 2023 Second Quarter Ended November 30, 2022 (GlobeNewswire)
Jan-10-23 08:19AM	Biomerica Appoints Mayo Clinic Gastroenterologist, Dr. Brian E. Lacy, to the Companys Scientific Advisory Board (GlobeNewswire)
Dec-08-22 08:19AM	Biomerica Receives KFDA and Ministry of Health Approval for Colorectal Screening and Breast Screening Tests in Saudi Arabia and UAE (GlobeNewswire)
Dec-01-22 05:12AM	We Think Shareholders May Consider Being More Generous With Biomerica, Inc.'s (NASDAQ:BMRA) CEO Compensation Package (Simply Wall St.) +6.32%
Nov-02-22 08:19AM	Biomerica InFoods® IBS Data Presented at the 2022 American College of Gastroenterology (ACG) Annual Scientific Meeting (GlobeNewswire)
Oct-14-22 10:24AM	Walmart Expands Sales Of Biomerica's Aware Breast Self Exam To 2400 Stores (Benzinga) -6.57%
09:46AM	Biomerica stock leaps as Walmart expands sales of Aware Breast Self Exam to its stores (MarketWatch)
09:18AM	Walmart to Expand Sales of Biomericas Aware® Breast Self Exam; Product will now be available in over 2400 Walmart stores (GlobeNewswire)
Oct-13-22 04:50PM	Biomerica Reports 30% Increase in Revenues for Fiscal Q1 2023 vs. Fiscal Q1 2022 (GlobeNewswire)
Oct-11-22 06:25AM	Those who invested in Biomerica (NASDAQ:BMRA) five years ago are up 39% (Simply Wall St.)
Sep-29-22 08:19AM	Biomericas Aware® Breast Self Exam and EZ Detect Colon Disease Test Now Available on Amazon and Fulfilled by Amazon (GlobeNewswire)
Aug-31-22 06:25AM	We're Interested To See How Biomerica (NASDAQ:BMRA) Uses Its Cash Hoard To Grow (Simply Wall St.)
Aug-30-22 08:19AM	Biomerica Plans Launch of InFoods® IBS Test; Names Robert Carlson as Chief Commercial Officer (GlobeNewswire)
Aug-29-22 04:41PM	Biomerica Reports Fiscal 2022 Year End Results (GlobeNewswire)
Jul-14-22 11:50AM	Walmart to Start Selling Biomerica's Aware Breast Self Exam Devices (Benzinga) +8.00%
08:19AM	Walmart to Begin Selling Biomericas Aware® Breast Self Exam (GlobeNewswire)
Jun-23-22 08:19AM	Biomerica to Participate at BTIG Biotech Conference (GlobeNewswire)
May-16-22 01:20PM	36 of the Best Ideas Companies to Present at the Spring into Action - Best Ideas Investor Conference on May 16th - 20th, 2022 (ACCESSWIRE) -6.40%
May-12-22 08:19AM	Biomerica Announces CE Mark for Its H. pylori Diagnostic Test, hp+detect (GlobeNewswire)
Apr-26-22 08:19AM	Biomerica Announces FDA Submission For a Test to Detect Helicobacter pylori (H. pylori), a Bacteria That Infects Approximately 35% of the US Population (GlobeNewswire)
Apr-14-22 08:37AM	Biomerica Reports 111% Increase in Q3 Fiscal 2022 Revenues to $7.6 million vs. Q3 Fiscal 2021 (GlobeNewswire)
Feb-08-22 12:27PM	Biomerica Posts Encouraging Results From InFoods Study As Irritable Bowel Syndrome Treatment (Benzinga)
06:39AM	Biomerica Announces Positive Topline Results from the Endpoint Clinical Trial of its InFoods® IBS Treatment for Patients with Irritable Bowel Syndrome (GlobeNewswire)
Jan-13-22 08:19AM	Biomerica Reports Record Financial Results for Fiscal Second Quarter ended November 30, 2021 (GlobeNewswire) -7.56%
Dec-16-21 08:19AM	Biomerica Announces Preliminary Second Quarter Revenue Increase of Approximately 238%, to Approximately $4.6 Million (GlobeNewswire)

Biomerica, Inc. engages in the development, manufacture, and marketing of medical diagnostic products designed for the early detection and monitoring of chronic diseases and medical conditions. The firm focuses on gastrointestinal diseases, food intolerances, diabetes, and certain esoteric tests. It operates through the following geographical segments: Europe, North America, Asia, South America, and Middle East. The company was founded in September 1971 and is headquartered in Irvine, CA.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

BMRA

Biomerica Inc

Upgrade your Finviz experience